Objective-The melanocortin 1 receptor (MC1-R) is expressed by vascular endothelial cells and shown to enhance nitric oxide (NO) availability and vasodilator function on pharmacological stimulation. However, the physiological role of MC1-R in the endothelium and its contribution to vascular homeostasis remain unresolved. We investigated whether a lack of functional MC1-R signaling carries a phenotype with predisposition to vascular abnormalities. Approach and Results-Recessive yellow mice (MC1R e/e ), deficient in MC1-R signaling, and their wild-type littermates were studied for morphology and functional characteristics of the aorta. MC1R
T he melanocortin system is a complex hormonal system that appeared early in vertebrate evolution. 1 It consists primarily of melanocortin peptides, derived from the precursor polypeptide pro-opiomelanocortin, and their cellular receptors. Post-translational processing of the pro-opiomelanocortin results in the formation of biologically active melanocortin peptides, which include adrenocorticotropic hormone and α-, β-, and γ-melanocyte-stimulating hormones (MSH). 2 These peptides exert their physiological functions through G-protein-coupled melanocortin receptors. In mammals, 5 structurally related and genetically highly conserved melanocortin receptor subtypes (MC1-R-MC5-R) have been identified, each of which couple mainly to G s proteins to activate adenylyl cyclase. 3 Of these 5 MC receptors, MC1-R has a well-defined role in the regulation of skin pigmentation and has been recently implicated in the control of inflammation. 4, 5 Intriguingly, MC1-R is also expressed in the vascular endothelium, 6 but the physiological role of endothelial MC1-R in vascular homeostasis has remained elusive.
The MC1-R is abundantly expressed in the skin and regulates melanin pigmentation, 7, 8 being the best characterized genetic determinant of human skin and hair color. Binding of the natural high-affinity ligand α-MSH promotes eumelanin synthesis in skin melanocytes, providing a photoprotective mechanism against sun-induced skin cancers, such as melanoma. The discovery that the human MC1-R gene is highly polymorphic, and an important melanoma susceptibility gene has attracted wide attention and led to major breakthroughs in understanding the impact of the various single nucleotide polymorphisms (SNP) on MC1-R function. 5, 9 Genetic studies have also identified several naturally occurring dominant and recessive alleles in the mouse MC1-R gene that are associated with atypical coat color. 10, 11 The recessive MC1R e/e mouse, characterized by yellow coat color, carries a nonfunctional MC1-R caused by a single base deletion mutation. 10 It serves as an experimental counterpart to human MC1-R variants that are known to associate with a pigmentation phenotype, namely the red hair color phenotype, caused by suppressed MC1-R function. 5 We have recently found that pharmacological activation of MC1-R enhances endothelium-dependent relaxations via a nitric oxide (NO)-dependent mechanism, thus protecting against endothelial dysfunction in mice. 12 Given this, combined with the knowledge of MC1-R variants and their impact on receptor function in mice and humans, 5 we set out to determine whether deficiency in MC1-R signaling predisposes to perturbations of vascular homeostasis. We characterized the vascular phenotype of the MC1R e/e mouse and found that loss of MC1-R function is associated with changes in endothelial function and arterial stiffness. Using the data from a longitudinal study, the Cardiovascular Risk in Young Finns Study, 13, 14 we then examined whether carriers of weak MC1-R function recapitulate some of the features observed in the MC1R e/e mouse.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

MC1R
e/e Mice Show Increased Collagen Deposition in the Aorta That Is Associated With Increased Pulse Pressure and Arterial Stiffness Because the expression of MC1-R and its natural ligand α-MSH has not been previously studied in histological sections of mouse or human arteries, we first immunostained cross sections of mouse aorta and human carotid artery for MC1-R and α-MSH. Strong positive staining was detected on the endothelial lining of mouse and human artery with a similar pattern of expression of both MC1-R and α-MSH ( Figure 1A and 1B) . It was of note that in the mouse aorta, MC1-R and α-MSH were faintly and uniformly expressed also on the vascular smooth muscle cell layer. To examine aortic morphology in MC1R e/e mice and age-matched wild-type (WT) controls, cross sections of the thoracic aorta were stained with hematoxylin and eosin and Van Gieson ( Figure 1C and 1D) . MC1R
e/e mice showed no changes in wall:lumen ratio or elastin content of the aorta ( Figure 1E and 1F) . However, perioaortic fibrosis, as visualized by Van Gieson staining, was increased in MC1R
e/e mice ( Figure 1G ). Tendency toward enhanced connective tissue formation was further evidenced by quantitative analysis of type 1 collagen (Col1A2) protein content of the whole aorta, revealing increased Col1A2 levels in MC1R
e/e mice ( Figure 1H ). To investigate whether the presence of augmented collagen deposition in MC1R
e/e mice is associated with an aberration in blood pressure regulation, systemic hemodynamics were monitored by radiotelemetry under physiological baseline conditions. Interestingly, we observed a reduction in diastolic blood pressure ( Figure 2B ), which was most prominent during daytime when mice are quiescent, and no alteration in systolic blood pressure or heart rate ( Figure 2A and 2C) . Consequently, arterial pulse pressure, the difference between systolic and diastolic blood pressure, was elevated in MC1R
e/e mice ( Figure 2D ), suggesting compromised aortic compliance in these mice. To further test this possibility, isolated aortae of WT and MC1R
e/e mice were studied for vascular distensibility. The stress-strain curve of the thoracic aorta of MC1R e/e mice was slightly but significantly shifted to the left, indicating increased aortic stiffness ( Figure 2E ).
Aortic Contractile Capacity and NO-Dependent Vasodilatation Are Impaired in MC1R
e/e Mice Because pharmacological activation of endothelial MC1-R has been previously shown to promote endothelium-dependent vasodilatation in the aorta, we sought to investigate whether MC1-R signaling contributes to the physiological regulation of endothelial function and tested the hypothesis that vascular relaxation responses are attenuated in MC1R e/e mice. First, we monitored responses to potassium-and phenylephrineevoked vasoconstriction and observed that the contractile responses were markedly blunted in the aorta of MC1R e/e mice ( Figure 3A and 3B), indicating vascular hypocontractility. Next, we examined endothelium-dependent relaxation responses to acetylcholine before and after inhibiting the tissue nitric oxide synthase (NOS) activity. There was no genotype effect in the maximal response to acetylcholine, but the sensitivity (EC 50 ) to acetylcholine-evoked vasodilatation was diminished in MC1R
e/e mice ( Figure 3D ). NOS inhibition attenuated the acetylcholine response more effectively in WT mice ( Figure 3E and 3F) , uncovering that the NO-dependent component of the initial acetylcholine response had reduced as a result of deficient MC1-R signaling. In contrast to aberrations in endothelium-dependent vasodilatation, the sensitivity of the vascular smooth muscle layer to endothelium-independent relaxation, ie, the response to the NO donor sodium nitroprusside, was not changed in MC1R
e/e mice compared with WT mice ( Figure 3C ).
Decreased NO Availability in MC1R
e/e Mice
To dissect more closely the underlying mechanisms leading to the defect in NO-dependent vasodilatation in MC1R e/e mice, we investigated the NO-cGMP pathway and established factors affecting the local availability of NO in the vasculature. We found that the serum concentration of NO metabolites, a surrogate marker of NO availability ( Figure 4A ), was reduced in MC1R e/e mice. This was supported by the finding of similarly reduced urinary excretion of NO metabolites (data not shown). Consistent with these findings, aortic NOS activity was also suppressed in these mice ( Figure 4B ). We then measured relative mRNA levels of endothelial NOS (eNOS) and antioxidant enzymes, which contribute to the NO availability by reducing reactive oxygen species-mediated breakdown of NO. In the aorta of MC1R
e/e mice, eNOS mRNA level tended (P=0.09) to be lower in comparison with WT mice ( Figure  4C ). Likewise, the expression of the antioxidant enzymes, manganese superoxide dismutase (MnSOD or SOD2), and catalase, which drive the decomposition of superoxide anions to hydrogen peroxide and further to water and oxygen, was reduced by the mutation in the MC1R gene, whereas the expression of glutathione peroxidase 1 (Gpx1) remained unchanged in MC1R
e/e mice ( Figure 4C ). Furthermore, we determined the phosphorylation status of eNOS at Ser1177, which regulates the enzymatic activity of eNOS. This activating phosphorylation tended to be reduced in MC1R e/e mice ( Figure 4D ).
Current evidence suggests a strong link between inflammation and endothelial dysfunction. Given this, combined with the established function of MC1-R in modulating inflammatory responses, we aimed to investigate whether proinflammatory cytokines are elevated because of dysfunctional MC1-R. Indeed, MC1R
e/e mice displayed elevated serum levels of interleukin (IL)-6 and chemokine (C-C motif) ligand (CCL) 2 ( Figure 4E ), the former representing a marker of general inflammation and the latter conveying chemotactic signal specifically for monocytes. Similar changes were also found at the mRNA level in the aorta of MC1R
e/e mice ( Figure 4F ). Overall, these data support the finding of vascular dysfunction in MC1R
e/e mice and suggest that the aberrant vascular phenotype, as assessed in terms of vasomotor function, is attributable to several factors including dysregulated eNOS and inflammation.
MC1R e/e Mice Display Increased Susceptibility to Inflammation-Driven Vascular Dysfunction
Having noted increased markers of systemic and local inflammation in MC1R
e/e mice under baseline conditions, we next challenged the mice with treatments that are known to evoke inflammatory stimuli and investigated whether it results in further deterioration of vascular function in MC1R
e/e mice. Exposure to a high-sodium diet for 4 weeks caused subtle increases in systolic blood pressure and heart rate, but both genotypes responded similarly to this challenge ( Figure 5A and 5B). Analysis of the same proinflammatory mediators as in Figure 4F revealed that the diet had exacerbated the inflammatory status of MC1R
e/e mice with peaking of IL-1β and CCL5 in addition to IL-6 ( Figure 5C ). In terms of aortic vasoreactivity, MC1R
e/e mice showed a pronounced weakening of the overall acetylcholine response compared with WT mice ( Figure 5D ). After NOS inhibition, there was a clear-cut difference between the genotypes in the acetylcholine response ( Figure 5E ), but the order of relaxation curves had reversed compared with control measurements ( Figure 3E ). This phenomenon indicates that once the endothelium-derived NO production becomes exhausted as a result of pathological processes, it can be compensated with other mechanisms such as vasodilatory prostacyclin or endothelium-derived hyperpolarizing factors. These compensatory mechanisms were harnessed in WT mice to maintain vascular homeostasis but seemed to be relatively ineffective in MC1R
e/e mice after 4 weeks of highsodium diet ( Figure 5F ).
In addition, we studied whether MC1R e/e mice are more prone to vascular dysfunction induced by lipopolysaccharide treatment. Lipopolysaccharide-treated mice showed a marked attenuation of potassium-evoked maximal contraction ( Figure 6A ), indicating that systemic inflammation suppresses contractile capacity of the aorta. However, phenylephrine-evoked maximal contraction, normalized to the reference potassium-stimulated contraction, was increased in MC1R
e/e mice compared with lipopolysaccharide-treated WT mice ( Figure 6B e/e mice show increased pulse pressure and arterial stiffness. A-C, Circadian rhythm of systolic and diastolic blood pressure (SBP and DBP, respectively) and heart rate (HR) in wild-type (WT) and MC1R e/e mice. The data represent physiological baseline conditions (days 8-10 after the implantation surgery). The dark period of the day from 6 pm to 6 am is marked in gray. Exact P values for the main genotype effect (ANOVA for repeated measures) are shown in the graphs. *P<0.05 vs WT at given time point, n=4 to 5 mice per group in each graph. D, Arterial pulse pressure calculated as the difference between 24-hour mean SBP and DBP. E, Stress-strain curve of the thoracic aorta of WT and MC1R
e/e mice (n=8 mice per group). **P<0.01 vs WT. Values are mean±SEM.
NO-independent component of the acetylcholine response were significantly reduced in MC1R
e/e mice ( Figure 6D -6F), unveiling that there was virtually no residual capacity for vasodilatation after NOS inhibition in these mice ( Figure  6E and 6F). To examine the lipopolysaccharide-induced activation of proinflammatory cytokines locally in the endothelium, we isolated aortic endothelial cells and evaluated the changes in gene expression after in vitro lipopolysaccharide treatment. Consistent with the mRNA expression in the whole aorta, endothelial cells from MC1R
e/e mice showed elevated mRNA levels of IL-6, CCL2, and CCL5 under baseline conditions ( Figure I in the online-only Data Supplement). Lipopolysaccharide challenge induced significant upregulation of IL-6 and CCL5 expression, and these changes were pronounced in MC1R
e/e endothelial cells. Taken together, these results demonstrate that deficiency in MC1R signaling aggravates vascular dysfunction associated with acute lipopolysaccharide-stimulated systemic inflammation.
Vascular Distensibility and Flow-Mediated Dilatation Are Impaired in Human Subjects Carrying Variants Associated With Weak MC1-R Function
On the basis of characteristics observed in MC1R
e/e mice, we finally explored whether dysfunctional MC1-R signaling is similarly associated with subclinical markers of atherosclerosis in healthy human subjects. To this end, we used the data (n=2001) from the Cardiovascular Risk in Young Finns Study and screened the study cohort for five MC1-R variants (rs1805005, rs1805007, rs1805008, rs1805009, and rs2228479) that are linked to weak receptor function and the consequent red hair color phenotype. 5 Characteristics of the study cohort and the 5 SNPs included in our analyses are presented in Tables I and II , in the online-only Data Supplement, respectively. We constructed a genetic risk score (GRS) and analyzed the association of weak MC1-R function with ultrasound measures of arterial function and elasticity. The maximum value of the GRS was 2.00, indicating that none of the e/e mice, and densitometric quantification of p-eNOS/ eNOS ratio. n=5 per group. E and F, Serum and aortic mRNA levels of interleukin (IL)-1β, IL-6, chemokine (C-C motif) ligand 2 (CCL2), and chemokine (C-C motif) ligand 5 (CCL5) in WT and MC1R
e/e mice. n=5 per group. *P<0.05 and **P<0.01 vs WT mice. Values are mean±SEM. subjects is homozygous for >1 risk variant. Because weak MC1-R signaling has been previously linked to increased serum vitamin D level, 15 we analyzed the association between the GRS and vitamin D concentration to verify that the constructed GRS corresponds to true genotypes and is sensitive enough to identify a previously recognized phenotype. Consistently, the GRS was directly associated with vitamin D levels (Table) , suggesting that carriers of weak MC1-R have lower melanin content in the skin, which could enhance UV radiation-induced cutaneous vitamin D synthesis.
The GRS was inversely associated (P=0.037) with brachial artery flow-mediated dilatation, reflecting an impairment in endothelium-dependent vasodilatation in the presence of ≥1 minor alleles (Table) . Likewise, the GRS was significantly (P=0.029) associated with carotid artery distensibility (CA dist ). Subjects carrying the minor alleles of MC1-R variants had lower CA dist values (Table) . Furthermore, we analyzed Young's elastic modulus, a marker of elasticity that takes into account arterial thickness. Carotid Young's elastic modulus was directly associated with the GRS (P=0.013), which in conjunction with the CA dist analysis refer to compromised arterial compliance in subjects carrying dysfunctional MC1-R. Statistical significances remained in brachial flow-mediated dilatation, carotid CA dist , and Young's elastic modulus after adjustment for mean arterial pressure (Table III in the onlineonly Data Supplement). We observed no significant associations between the GRS and blood pressure values, carotid artery luminal diameters, or carotid intima-media thickness (Table) . Least square means of the analyzed parameters were also calculated for carriers of normal (GRS<0.5) and weak (GRS>1.5) MC1-R function. These data are presented in Table IV in the online-only Data Supplement. Taken together, the human data indicate that weak MC1-R function is associated with impairments in arterial vasodilatation and distensibility, thereby supporting the findings in MC1R
e/e mice.
Discussion
The present study demonstrates a critical role for MC1-R in the regulation of vascular homeostasis. We show that deficiency in MC1-R signaling leads to a vascular phenotype with increased arterial stiffness and impairment of endothelial vasodilatory function. This phenotype was observed in The effect estimates (β) indicate the parameter change per a 1-U increase in the genetic risk score. The model was adjusted with age, sex, and body mass index. These data are from 2 time points (2001 and 2007) . BP indicates blood pressure; CA dist , carotid artery distensibility; FMD, flow-mediated dilatation; IMT, intima-media thickness; and YEM, Young's elastic modulus.
the MC1R
e/e mouse carrying a nonfunctional receptor and in human carriers of a loss-of-function mutation in the MC1-R gene. The observed changes often precede the development of clinical atherosclerosis and thereby suggest that MC1-R dysfunction might increase the risk of atherosclerosis and associated cardiovascular complications.
Previous studies have demonstrated that significant MC1-R expression is present in isolated and cultured endothelial cells using polymerase chain reaction-based methods and Western blotting. 12, 16 We first aimed to verify that the expression is also detectable in arterial sections by immunohistochemistry. Indeed, MC1-R was distinctively expressed on endothelial cells of mouse and human arteries. We also show that the natural ligand α-MSH follows the same expression pattern as MC1-R, implying that α-MSH might signal via MC1-R in an autocrine or paracrine fashion in the vasculature. We then sought to investigate whether MC1-R dysfunction affects structural or functional properties of the aorta in MC1R
e/e mice. We found that the relative amount of type I collagen, which is one of the main constituents of aortic collagen, was elevated in MC1R
e/e mice. This was further supported by the finding of increased Van Gieson staining of the aorta. Consistent with our findings, MC1-R has been recently implicated in the control of cutaneous collagen synthesis. Treatment with α-MSH by activating MC1-R in fibroblasts suppressed collagen deposition in experimental models of skin fibrosis, 17 whereas MC1R e/e mice showed increased formation of cutaneous type I collagen compared with WT mice in similar models. 18 These observations lend support to the concept that MC1-R might have a regulatory role also in aortic collagen synthesis and deposition. Extending this further to physiological consequences, we noted that aortic compliance, as evidenced by increased mechanical stiffness and pulse pressure, was compromised in MC1R
e/e mice. Collagen is an important component of the aortic wall, contributing to the functional and mechanical properties of the aorta. Increments in arterial collagen content and the resultant decrease in compliance are typical changes in the aging vasculature and risk factors for several cardiovascular outcomes, emphasizing the significance of our findings in MC1R
e/e mice. In the present study, we primarily focused on evaluating whether endothelium-dependent vasodilatation and vascular NO availability are attenuated as a result of deficient MC1-R signaling. Although the overall acetylcholine-evoked vasodilatation was not markedly impaired under baseline conditions, we observed that the mechanisms mediating the relaxation response were distorted in MC1R
e/e mice. Specifically, the contribution of endothelium-derived NO to aortic vasodilatation was reduced in these mice. This was further supported by the findings of decreased systemic and local NO availability. Endothelial NO formation is typically the predominant mediator of the acetylcholine response in larger arteries, but once it starts to fail, it can be compensated with other vasodilatory mechanisms. This phenomenon became evident when the mice were challenged with dietary sodium excess. Unlike WT mice, which were able to compensate the failing NO system with other mechanisms to maintain adequate relaxation response, MC1R
e/e mice showed deterioration of the acetylcholine-evoked vasodilatation when the compensatory mechanism had also exhausted. In the quest of the mechanistic explanation for the reduced NO availability, we analyzed the expression levels of eNOS and its phosphorylated isoform. MC1R
e/e mice displayed tendencies toward lower eNOS mRNA expression and eNOS phosphorylation at the activating Ser1177 residue. Expanding on these data, we show that nonfunctional MC1-R causes also downregulation of catalase and MnSOD, which might concomitantly reduce NO availability by interrupting the antioxidant systems that protect against reactive oxygen species-mediated breakdown of NO. These findings are well in line with our previous study showing that α-MSH upregulates the expression of Ser1177-phosporylated eNOS, total eNOS, and MnSOD in cultured human endothelial cells. 12 Under physiological baseline conditions, MC1R
e/e mice also showed elevated levels of local and systemic proinflammatory cytokines. Considering that low-grade inflammation localized in vascular tissue is recognized as a contributing factor to the development of vascular dysfunction, 19 there might be causality between the increased cytokine expression and the impaired vasoreactivity in MC1R
e/e mice. Although there has been controversies over the importance of MC1-R in modulating inflammatory responses in the skin, 20 ,21 several studies have shown that selective activation of the MC1-R by pharmacological means suppresses inflammatory responses in other disease models, such as vasculitis and lung inflammation. 22, 23 However, to the best of our knowledge, no study has ever demonstrated that deficient MC1-R function is inherently associated with inflammation. Accordingly, the data on the inflammatory profile of MC1R e/e mice provide novel insights into the role of MC1-R as a physiological regulator of inflammatory responses. In addition, moving toward a more pathological condition like the sodium-loaded state revealed peaking of systemic inflammation markers (IL-1β and IL-6) and led to generalized endothelial dysfunction in MC1R e/e mice. Although we observed a tendency toward proinflammatory phenotype also in isolated endothelial cells, one of the limitations of the present study is, however, that we cannot draw direct conclusions on the contribution of endothelial MC1-R and local inflammation to the vascular dysfunction observed in the MC1R e/e mice. A distinctive feature of MC1R e/e mice was the hyporesponsiveness to contractions evoked by phenylephrine and 62 mmol/L K + . This was an unexpected finding and is lacking clear explanation. Endotoxin exposure, leading to a highgrade inflammatory state, caused a clear-cut reduction in the maximal contractile capacity only in WT mice, suggesting that the basal hyporesponsiveness of MC1R
e/e mice to vasoconstriction is, at least in part, attributable to inflammatory factors. It is known that proinflammatory cytokines induce hyporeactivity to certain vasoconstrictors. 24 Conversely, they can also enhance vasoconstrictor responses to other agents because of the loss of endothelial integrity to blunt these responses. 24, 25 This might explain why the relative contraction to phenylephrine was significantly increased in MC1R
e/e mice after lipopolysaccharide treatment. Aside from the possible inflammation-driven mechanisms, MC1-R-positive cells were also found in the smooth muscle cell layer of immunohistochemical staining, raising a question whether MC1-R could directly regulate vascular smooth muscle architecture and functional contractile output. Additional studies are warranted to investigate this possibility.
To extend the findings in MC1R e/e mice to a clinical perspective, we explored the association of human MC1-R variants to early markers of atherosclerotic changes. The vascular phenotype of MC1R e/e mice was highly concordant with the data from young adults. First, brachial artery flow-mediated dilatation, which is primarily dependent on endothelial NO availability, 26 was lower in carriers of variant MC1-R alleles. Second, carotid artery stiffness, as evidenced by 2 separate ultrasound-based indices, was higher in these subjects. Because the frequencies of the minor alleles of MC1-R polymorphisms were relatively low, we generated a multilocus profile of genetic risk by combining 5 MC1-R SNPs (rs1805007, rs1805008, rs1805009, rs2228479, and rs1805005). The first 3 of these SNPs have been defined as strong red hair color variants based on their diminished receptor function and specific phenotypic signature, namely red/blonde hair, fair skin, and freckling. 5 The 2 other SNPs have been reported to reduce binding affinity to α-MSH and functional coupling of MC1-R to intracellular second messengers, but are only weakly associated with the red hair color phenotype. These variants were well presented in the study cohort and thus included in the construction of the GRS. By aggregating information from multiple SNPs, the analysis became less sensitive for the low frequency of minor alleles of individual SNPs. A considerable limitation is, however, that the analysis does not allow exploring linkage between individual SNPs and cardiovascular risk markers. It should also be taken into account that this type of association study is based on a common variant-common disease hypothesis, according to which common variants influence a complex disease by exerting small additive effects on the phenotype. This explains why the observed effect of weak MC1-R function on the vascular phenotype was relatively small. Nevertheless, the major strength of this study was the longitudinal approach including well-established ultrasound measurements from 2 time points and a relatively large sample size. Collectively, the human data support the findings in MC1R
e/e mice and demonstrate the significant association of MC1-R variants to markers of systemic endothelial function and arterial distensibility that predict cardiovascular events. 27, 28 In conclusion, the present study extends the role of MC1-R beyond its protective effects in the skin to a novel significance in the regulation of arterial tone. We show, by uniquely linking mouse and human data, that deficiency in MC1-R signaling is associated with reduced NO availability and endothelial dysfunction, as well as with increased arterial stiffness.
